All Type of News
Severance succeeds in expanding to foreign country for the first time
Severance will found a general hospital in a foreign country for the first time among domestic medical institutions.
On the 22nd, Severance announced a partnership agreement to found a joint company with Hiking Group...
8 of 10 ECCO members trust Celltrion’s RemsimaAt the 11th European Crohn’s and Colitis Organization(ECCO) held in Amsterdam, Netherlands from 16th to 19th of March, a survey was announced 8 of 10 ECCO members trust biosimil...
|
Average pharmaceutical companies’ inventory asset turnover period is 65 days
It was analyzed it takes about 65 days for a listed pharmaceutical company’s manufactured product in a storage to be exhausted.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ lis...
‘Biosimilar’ development takes largest portion in pharmaceutical R&D expensess
A field with the largest pharmaceutical R&D expenses was turned out to be the biosimilar field.
The Korea Health Industry Development Institute announced through the recent ‘2014 Pharmaceutical Product/Medical Devic...
Merging process of Pfizer and Allergan starts
Pfizer and Allergan will become one.
Recognized as the most interesting deal of the last year, the merger of the two companies has been visualized.
According to the industry concerned on the 22nd, the Pfizer’s hea...
Multinational pharmaceuticals’ distribution policies as ‘Selection and Concentration’
Multinational pharmaceutical companies have started to change their marketing policies to ‘Selection and Concentration.’
According to the industry concerned on the 22nd, Boehringer Ingelheim recently opened cooperati...
About 10 companies cannot even pay back interests with profitsAmong listed pharmaceutical companies, it was observed there were 10 companies which cannot even pay for interests of their loans with earnings made by their business activities...
|
Listed pharmaceutical companies spent KRW 500 billion into advertising
It was observed listed pharmaceutical companies exceeded KRW 50 million in spending expenses into advertising last year.
This is because a number of pharmaceutical companies have actively worked on invigoration of no...
Will rebate investigation team investigate Japanese companies too?
While a large multinational pharmaceutical company, Novartis, has become a target for prosecution investigation, the industry has paid attention to which will be the next target of the rebate investigation team.
As ...
3-year GMP investment of KRW 1 trillion
Domestic pharmaceutical companies were observed to put approximately KRW 1 trillion into establishing GMP facilities for 3 years from this year to 2018.
Thus, the pharmaceutical industry has paid attention to expansi...
